Home › Sleep Apnea › NCT06089161
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
Recruiting
Who can join
Ages 60 to 85 · All sexes
Full eligibility criteria
Inclusion Criteria: * Self-reported race/ethnicity as African American, African, Caribbean or black * Ages 60-85 years * accessible by phone * OSA diagnosis * consent, including permission to release medical data Exclusion Criteria: * progressive illnesses in which disability or death is expected within 1 year * impaired cognitive/ functional ability precluding participation * intention to move within the year * and a family member currently enrolled.
About the study
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
What is being tested
- Standard of Care (other)
- Personalized OSA Treatment (behavioral)
Sponsor: University of Miami · Participants: 330 · Started: Mar 19, 2024
Contact the study team
- Girardin Jean-Louis, PhD · Phone: 3052430776
Official record on ClinicalTrials.gov — NCT06089161
Locations in the U.S.
| Florida | University of Miami, Miami |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.